• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病相关的睡眠障碍。

Sleep disturbances associated with Parkinson's disease.

机构信息

Department of Neurology, Center of Sleep Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Shimotsuga, Tochigi 321-0293, Japan.

出版信息

Parkinsons Dis. 2011;2011:219056. doi: 10.4061/2011/219056. Epub 2011 Aug 17.

DOI:10.4061/2011/219056
PMID:21876839
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3159123/
Abstract

Sleep disturbances are common problems affecting the quality life of Parkinson's disease (PD) patients and are often underestimated. The causes of sleep disturbances are multifactorial and include nocturnal motor disturbances, nocturia, depressive symptoms, and medication use. Comorbidity of PD with sleep apnea syndrome, restless legs syndrome, rapid eye movement sleep behavior disorder, or circadian cycle disruption also results in impaired sleep. In addition, the involvement of serotoninergic, noradrenergic, and cholinergic neurons in the brainstem as a disease-related change contributes to impaired sleep structures. Excessive daytime sleepiness is not only secondary to nocturnal disturbances or dopaminergic medication but may also be due to independent mechanisms related to impairments in ascending arousal system and the orexin system. Notably, several recent lines of evidence suggest a strong link between rapid eye movement sleep behavior disorder and the risk of neurodegenerative diseases such as PD. In the present paper, we review the current literature concerning sleep disorders in PD.

摘要

睡眠障碍是常见问题,会影响帕金森病 (PD) 患者的生活质量,且常被低估。睡眠障碍的原因是多因素的,包括夜间运动障碍、夜尿症、抑郁症状和药物使用。PD 合并睡眠呼吸暂停综合征、不安腿综合征、快速眼动睡眠行为障碍或昼夜节律紊乱也会导致睡眠受损。此外,中脑内 5-羟色胺能、去甲肾上腺素能和胆碱能神经元作为与疾病相关的变化,导致睡眠结构受损。白天过度嗜睡不仅是夜间紊乱或多巴胺能药物的继发症状,也可能与上行觉醒系统和食欲素系统损伤相关的独立机制有关。值得注意的是,最近有几项证据表明,快速眼动睡眠行为障碍与帕金森病等神经退行性疾病的风险之间存在很强的关联。本文综述了与 PD 相关的睡眠障碍的现有文献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f647/3159123/cbdb370d07ae/PD2011-219056.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f647/3159123/cbdb370d07ae/PD2011-219056.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f647/3159123/cbdb370d07ae/PD2011-219056.001.jpg

相似文献

1
Sleep disturbances associated with Parkinson's disease.帕金森病相关的睡眠障碍。
Parkinsons Dis. 2011;2011:219056. doi: 10.4061/2011/219056. Epub 2011 Aug 17.
2
Parkinson's disease and sleep/wake disturbances.帕金森病与睡眠/觉醒障碍。
Curr Neurol Neurosci Rep. 2015 Mar;15(3):8. doi: 10.1007/s11910-015-0525-5.
3
Detection and management of sleep disturbances in Parkinson's disease.帕金森病睡眠障碍的检测与管理
Nihon Rinsho. 2017 Jan;75(1):125-135.
4
Current Update on Clinically Relevant Sleep Issues in Parkinson's Disease: A Narrative Review.目前帕金森病相关临床睡眠问题的最新研究进展:综述。
J Parkinsons Dis. 2021;11(3):971-992. doi: 10.3233/JPD-202425.
5
Management of Sleep Disturbances in Parkinson's Disease.帕金森病睡眠障碍的管理。
J Parkinsons Dis. 2022;12(7):2029-2058. doi: 10.3233/JPD-212749.
6
Sleep-wake disturbances in Parkinson's disease: current evidence regarding diagnostic and therapeutic decisions.帕金森病的睡眠-觉醒障碍:关于诊断和治疗决策的当前证据。
Eur Neurol. 2012;67(5):257-67. doi: 10.1159/000335078. Epub 2012 Mar 30.
7
A Review of Scales to Evaluate Sleep Disturbances in Movement Disorders.运动障碍睡眠障碍评估量表综述
Front Neurol. 2018 May 29;9:369. doi: 10.3389/fneur.2018.00369. eCollection 2018.
8
The Genetic Landscape of Sleep Disorders in Parkinson's Disease.帕金森病睡眠障碍的遗传图谱
Diagnostics (Basel). 2024 Jan 3;14(1):106. doi: 10.3390/diagnostics14010106.
9
[Syndrome of rapid eye movement sleep behavior disorder and nocturia in Parkinson's disease].帕金森病中的快速眼动睡眠行为障碍与夜尿症综合征
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(9):15-20. doi: 10.17116/jnevro20171179115-20.
10
Sleep Dysfunction in Parkinson's Disease.帕金森病中的睡眠功能障碍
Int Rev Neurobiol. 2017;133:719-742. doi: 10.1016/bs.irn.2017.05.033. Epub 2017 Jul 10.

引用本文的文献

1
Efficacy and safety of continuous subcutaneous ND0612 Infusion compared to oral and alternative regimens in managing motor fluctuations in Parkinson's disease: a systematic review and meta-analysis.与口服及其他治疗方案相比,持续皮下输注ND0612治疗帕金森病运动波动的疗效和安全性:一项系统评价和荟萃分析
Neurol Sci. 2025 Jun 2. doi: 10.1007/s10072-025-08257-w.
2
Subregion-specific associations of the basal forebrain with sleep and cognition in Parkinson's disease.帕金森病中基底前脑与睡眠和认知的特定亚区域关联。
NPJ Parkinsons Dis. 2025 Feb 20;11(1):33. doi: 10.1038/s41531-025-00880-w.
3
Efficacy of hyperbaric oxygen therapy as an adjunct therapy in the treatment of sleep disorders among patients with Parkinson's disease: a meta-analysis.

本文引用的文献

1
Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER).罗替戈汀对帕金森病患者清晨运动功能和睡眠的影响:一项双盲、随机、安慰剂对照研究(RECOVER)。
Mov Disord. 2011 Jan;26(1):90-9. doi: 10.1002/mds.23441. Epub 2010 Nov 18.
2
Parkinson's disease sleep scale--validation of the revised version PDSS-2.帕金森病睡眠量表-修订版 PDSS-2 的验证。
Mov Disord. 2011 Mar;26(4):644-52. doi: 10.1002/mds.23476. Epub 2011 Feb 10.
3
Scales to assess sleep impairment in Parkinson's disease: critique and recommendations.
高压氧疗法作为辅助治疗帕金森病患者睡眠障碍的疗效:一项荟萃分析。
Front Neurol. 2024 Jul 31;15:1328911. doi: 10.3389/fneur.2024.1328911. eCollection 2024.
4
Effects of Age and MPTP-Induced Parkinson's Disease on the Expression of Genes Associated with the Regulation of the Sleep-Wake Cycle in Mice.年龄和 MPTP 诱导的帕金森病对与调节小鼠睡眠-觉醒周期相关的基因表达的影响。
Int J Mol Sci. 2024 Jul 14;25(14):7721. doi: 10.3390/ijms25147721.
5
Anesthetic Considerations for Cataract Surgery in Patients with Parkinson's Disease: A Narrative Review.帕金森病患者白内障手术的麻醉考量:一项叙述性综述
Anesth Pain Med. 2023 May 6;13(3):e136093. doi: 10.5812/aapm-136093. eCollection 2023 Jun.
6
Evaluation of Nocturnal Symptoms in Chinese Parkinson's Disease Patients Based on the PDSS-2 Scale: A Multicenter Cross-Sectional Study.基于 PDSS-2 量表评估中国帕金森病患者的夜间症状:一项多中心横断面研究。
J Parkinsons Dis. 2023;13(6):1061-1071. doi: 10.3233/JPD-230060.
7
Blood pressure variability in Parkinson's Disease patients - Case control study.帕金森病患者的血压变异性——病例对照研究。
Clin Park Relat Disord. 2023 Mar 1;8:100191. doi: 10.1016/j.prdoa.2023.100191. eCollection 2023.
8
Parkinsonian daytime sleep-wake classification using deep brain stimulation lead recordings.使用深部脑刺激导联记录对帕金森日间睡眠-觉醒进行分类。
Neurobiol Dis. 2023 Jan;176:105963. doi: 10.1016/j.nbd.2022.105963. Epub 2022 Dec 12.
9
Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson's Disease Cohort.澳大利亚帕金森病队列中肠道微生物群的变化及预测的功能代谢效应
Front Neurosci. 2021 Oct 29;15:756951. doi: 10.3389/fnins.2021.756951. eCollection 2021.
10
The effect of camel milk curd masses on rats blood serum biochemical parameters: Preliminary study.骆驼奶凝乳块对大鼠血清生化参数的影响:初步研究。
PLoS One. 2021 Sep 29;16(9):e0256661. doi: 10.1371/journal.pone.0256661. eCollection 2021.
评估帕金森病睡眠障碍的量表:评价与建议。
Mov Disord. 2010 Dec 15;25(16):2704-16. doi: 10.1002/mds.23190.
4
The early and accurate objective diagnosis of RBD--why should we care?快速眼动睡眠行为障碍的早期准确客观诊断——我们为何要关注?
Mov Disord. 2010 Oct 15;25(13):2003-5. doi: 10.1002/mds.23282.
5
Prevalence and clinical profile of restless legs syndrome in Parkinson's disease.帕金森病患者不安腿综合征的患病率和临床特征。
Mov Disord. 2010 Oct 15;25(13):2142-7. doi: 10.1002/mds.23241.
6
Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder.特发性 REM 睡眠行为障碍中的心脏自主神经功能障碍。
Mov Disord. 2010 Oct 30;25(14):2304-10. doi: 10.1002/mds.23347.
7
No increased risk of obstructive sleep apnea in Parkinson's disease.帕金森病患者阻塞性睡眠呼吸暂停风险无增加。
Mov Disord. 2010 Oct 15;25(13):2246-9. doi: 10.1002/mds.23231.
8
REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century.快动眼睡眠行为障碍在其他突触核蛋白病出现前可长达半个世纪。
Neurology. 2010 Aug 10;75(6):494-9. doi: 10.1212/WNL.0b013e3181ec7fac. Epub 2010 Jul 28.
9
Transcranial brain sonography in Parkinson's disease with restless legs syndrome.经颅脑超声在帕金森病伴不宁腿综合征中的应用。
Mov Disord. 2010 Jul 30;25(10):1373-8. doi: 10.1002/mds.23066.
10
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.普拉克索治疗帕金森病患者抑郁症状的随机、双盲、安慰剂对照试验。
Lancet Neurol. 2010 Jun;9(6):573-80. doi: 10.1016/S1474-4422(10)70106-X. Epub 2010 May 7.